Follow this preprint
Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
Sandile Cele, Mallory Bernstein, View ORCID ProfileFarina Karim, Khadija Khan, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Gila Lustig, Natasha Samsunder, Matilda Mazibuko, Shi-Hsia Hwa, Nithendra Manickchund, Anne von Gottberg, Nombulelo Magula, View ORCID ProfileRichard J. Lessells, View ORCID ProfileTulio de Oliveira, Salim S. Abdool Karim, Willem Hanekom, COMMIT-KZN Team, Bernadett I. Gosnell, View ORCID ProfileMahomed-Yunus S. Moosa, View ORCID ProfileAlex Sigal
doi: https://doi.org/10.1101/2022.04.15.22273711
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Sandile Cele
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Mallory Bernstein
1Africa Health Research Institute, Durban, South Africa
Farina Karim
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Khadija Khan
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
Yashica Ganga
1Africa Health Research Institute, Durban, South Africa
Zesuliwe Jule
1Africa Health Research Institute, Durban, South Africa
Kajal Reedoy
1Africa Health Research Institute, Durban, South Africa
Gila Lustig
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
Natasha Samsunder
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
Matilda Mazibuko
1Africa Health Research Institute, Durban, South Africa
Shi-Hsia Hwa
1Africa Health Research Institute, Durban, South Africa
Nithendra Manickchund
4Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Anne von Gottberg
5National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
6SAMRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Nombulelo Magula
7Department of Internal Medicine, Nelson R. Mandela School of Medicine. University of Kwa-Zulu Natal
Richard J. Lessells
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
8KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
Tulio de Oliveira
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
8KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
9Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
10Department of Global Health, University of Washington, Seattle, USA
Salim S. Abdool Karim
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
11Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
Willem Hanekom
1Africa Health Research Institute, Durban, South Africa
12Division of Infection and Immunity, University College London, London, UK
Bernadett I. Gosnell
4Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Mahomed-Yunus S. Moosa
4Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Alex Sigal
1Africa Health Research Institute, Durban, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
13Max Planck Institute for Infection Biology, Berlin, Germany

Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 15, 2022.
Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
Sandile Cele, Mallory Bernstein, Farina Karim, Khadija Khan, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Gila Lustig, Natasha Samsunder, Matilda Mazibuko, Shi-Hsia Hwa, Nithendra Manickchund, Anne von Gottberg, Nombulelo Magula, Richard J. Lessells, Tulio de Oliveira, Salim S. Abdool Karim, Willem Hanekom, COMMIT-KZN Team, Bernadett I. Gosnell, Mahomed-Yunus S. Moosa, Alex Sigal
medRxiv 2022.04.15.22273711; doi: https://doi.org/10.1101/2022.04.15.22273711
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (409)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3059)
- Dermatology (258)
- Emergency Medicine (458)
- Epidemiology (12991)
- Forensic Medicine (13)
- Gastroenterology (855)
- Genetic and Genomic Medicine (4796)
- Geriatric Medicine (443)
- Health Economics (748)
- Health Informatics (3041)
- Health Policy (1098)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (452)
- Medical Ethics (119)
- Nephrology (495)
- Neurology (4568)
- Nursing (243)
- Nutrition (675)
- Oncology (2370)
- Ophthalmology (671)
- Orthopedics (266)
- Otolaryngology (332)
- Pain Medicine (298)
- Palliative Medicine (86)
- Pathology (514)
- Pediatrics (1234)
- Primary Care Research (516)
- Public and Global Health (7153)
- Radiology and Imaging (1590)
- Respiratory Medicine (941)
- Rheumatology (457)
- Sports Medicine (399)
- Surgery (506)
- Toxicology (64)
- Transplantation (218)
- Urology (188)